Diffuse pulmonary development disorders- Molecular definable causes of pulmonary hypertension in the mature newborn

Meike Hengst (Munich, Germany), Meike Hengst, Nicolaus Schwerk, Jost Wigand Richter, Hans Fuchs, Lars Welzing, Mathias Klemme, Matthias Griese

Source: International Congress 2015 – Neonatal and paediatric intensive care
Session: Neonatal and paediatric intensive care
Session type: Poster Discussion
Number: 1867
Disease area: Paediatric lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Meike Hengst (Munich, Germany), Meike Hengst, Nicolaus Schwerk, Jost Wigand Richter, Hans Fuchs, Lars Welzing, Mathias Klemme, Matthias Griese. Diffuse pulmonary development disorders- Molecular definable causes of pulmonary hypertension in the mature newborn. Eur Respir J 2015; 46: Suppl. 59, 1867

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary hypertension in idiopathic pulmonary fibrosis: Utility of HRCT
Source: International Congress 2014 – COPD and PAH related imaging
Year: 2014

Unique characteristics of patients with pulmonary arterial hypertension associated with congenital heart disease compared to the rest of pulmonary arterial hypertension subgroups
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014


Limited and heterogeneous arterial narrowing in idiopathic pulmonary hypertension: Rethinking resistance
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015

Diagnosing pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension
Year: 2015



Pulmonary hypertension in children
Source: Eur Respir Mon 2012; 57: 94-107
Year: 2012


Pulmonary hypertension: a paradigm for rare pulmonary diseases
Source: Eur Respir Rev, 26 (146) 170120; 10.1183/16000617.0120-2017
Year: 2017



Pulmonary hypertension correction in patients with chronic obstructive pulmonary disease and essential hypertension
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014


Non-invasive haemodynamic measurement to detect treatment response in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014

Mitomycin-induced pulmonary veno-occlusive disease: Experience from the French pulmonary hypertension network
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015


Pulmonary arterial lesions and interstitial remodeling patterns in histology differentiate EIF2AK4 mutation-carriers from non-carriers with pulmonary veno-occlusive disease
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015


Pulmonary hypertension in patients with idiopathic pulmonary fibrosis
Source: Eur Respir Mon 2012; 57: 148-160
Year: 2012


Pulmonary hypertension: pathophysiology and diagnosis
Source: Annual Congress 2007 - PG19 - Pulmonary vascular disorders: diagnosis and treatment
Year: 2007



The incidence of chronic thromboembolic pulmonary hypertension secondary to acute pulmonary thromboembolism
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014

Right ventricular lymphatic insufficiency is associated with increased edema in pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013

Pulmonary hypertension in idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010

mir-126 contribute to angiogenesis defect in pulmonary arterial hypertension right ventricle failure
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014

Specific pulmonary arterial hypertension therapy in COPD patients with severe pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014


Smad1 deficiency and female gender contribute to the development of pulmonary hypertension
Source: International Congress 2014 – Pathobiology of pulmonary hypertension
Year: 2014


Quality of life of patients with pulmonary arterial hypertension associated with congenital heart disease: The multicenter cross-sectional ACHILLE study
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014


Pulmonary vascular reactivity in pulmonary hypertension due to left heart disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013